Ali McBride from the University of Arizona Cancer Center and colleagues discuss a number of topics pertaining to immune thrombocytopenia (ITP), including the diagnosis, clinical manifestations, traditional treatment options, and the advances we’ve seen in the past few years.

How long might immunity to the coronavirus last? Years, maybe even decades, according to a new study – the most hopeful answer yet to a question that has shadowed plans for widespread vaccination. These studies "are all by and large painting the same picture, which is that once you get past those first few critical weeks, the rest of the response looks pretty conventional," said Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine – Tucson who was not involved in the studies.

A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.

Researchers are expanding research showing that creating good sleeping habits can help people quit smoking to focus on smokers who are HIV positive.

An early interest in how the mind works led Dr. Rastogi to specialize in pediatric headaches, a widespread and under-studied health problem.

Arizona was in the bottom tier in three of six categories in a new American Lung Association report, which put the state dead-last for the number of patients who receive treatment after getting a diagnosis of lung cancer. Dr. Dan Derksen, associate vice president for Health Equity, Outreach & Interprofessional Activities at the University of Arizona Health Sciences, said racial and ethnic data jumped out to him because of Arizona's relatively large Hispanic and Native American populations. "Those populations are disproportionately affected for a number of reasons," he said, including the cost of health insurance, as well as cost of and access to preventive health services.

Researchers found no significant difference for all-cause mortality or cardiopulmonary hospitalization among patients who received the high-dose influenza vaccine compared with those who received the lower dose. Dr. Martha Gulati, Division Chief of Cardiology at the University of Arizona College of Medicine – Phoenix, provides perspective on the study.

Dr. Murtaza Akhter, an assistant professor at the University of Arizona College of Medicine answers MSNBC viewer questions about the coronavirus vaccine.

How long might immunity to the coronavirus last? Years, maybe even decades, according to a new study – the most hopeful answer yet to a question that has shadowed plans for widespread vaccination. These studies "are all by and large painting the same picture, which is that once you get past those first few critical weeks, the rest of the response looks pretty conventional," said Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine – Tucson who was not involved in the studies.